Table 1. Basic characteristics of the included studies.
Study (year) | Country | Type of study | Experimental group | Control group | |||
---|---|---|---|---|---|---|---|
Sample size | Age, years | Sample size | Age, years | ||||
Kurku, 2019 | Turkey | Case-control | 101 | 13.2±1.6 | 18 | 13.1±2.3 | |
Malecki, 2020 | Poland | Case-control | 16 | 11.0±2.2 | 14 | 10.6±4.5 | |
Kwon, 2020 | Korea | Case-control | 53 | 10.8±1.3 | 73 | 10.8±1.4 | |
Thompson, 2017 | USA | Case-control | 20 | 13.2±3.1 | 10 | 13.8±2.1 | |
Battal, 2018 | Turkey | Case-control | 32 | 13.3±2.8 | 24 | 12.8±3.3 | |
Elkabany, 2020 | Egypt | Case-control | 31 | 9.98±3.39 | 49 | 8.3±2.73 | |
Gupta, 2020 | India | Case-control | 62 | 10.52±2.2 | 38 | 9.32±2.4 | |
Hattar, 2011 | USA | Case-control | 20 | 12.2±2 | 17 | 12.4±2.1 | |
Hu W, 2017 | China | Case-control | 29 | 10.23±1.35 | 16 | 9.72±1.61 | |
Liu F, 2022 | China | Case-control | 48 | 11.24±0.59 | 54 | 10.16±0.48 | |
Antunes, 2013 | Brazil | Clinical trial | 34 | 13.6±1.1 | 34 | 13.6±1.0 | |
Grønbæk H, 2012 | Denmark | Clinical trial | 117 | 12.3±1.3 | 117 | 12.1±1.3 | |
Grønbæk H, 2012 | Denmark | Clinical trial | 71 | 13.4±1.3 | 117 | 12.1±1.3 | |
Koot BG, 2011 | The Netherlands | Clinical trial | 144 | 14.1±2.3 | 144 | 14.1±2.3 | |
Verduci, 2013 | Italy | Clinical trial | 46 | 6–14 | 46 | 6–14 | |
Nier, 2018 | Austria | Clinical trial | 16 | 7.8±0.3 | 36 | 7.3±0.2 |
Data are shown as number, range, or mean ± standard deviation.